Syneron Medical Ltd. (NASDAQ:ELOS)

CAPS Rating: 3 out of 5

The Company designs, develops and markets innovative aesthetic medical products based on its ELOS, technology, which uses the synergy between electrical energy and optical energy to provide effective, safe and affordable aesthetic medical treatments.

Results 1 - 20 of 95 : 1 2 3 4 5 Next »

Recs

0
Member Avatar AngieLaz (< 20) Submitted: 12/22/2013 10:36:27 PM : Outperform Start Price: $12.18 ELOS Score: -29.19

Laser aethetics such as tattoo removal, hair removal, and anti-aging treatments are replacing surgical techniques due to cost, efficacy and down-time. This is an industry that has shown to increase in sales during times of poor economics due to competition in the job market. In addition, baby boomers are living long, healthy lives and want to maintain and/or improve their appearances. Laser Technology Rox!

Recs

0
Member Avatar GreatStocks3728 (< 20) Submitted: 4/16/2010 8:28:45 AM : Outperform Start Price: $11.05 ELOS Score: -78.41

Good earnings.

Recs

1
Member Avatar foolstracker (< 20) Submitted: 4/11/2010 5:36:32 PM : Outperform Start Price: $10.80 ELOS Score: -77.91

stock of the day

Recs

0
Member Avatar chrisp9 (72.47) Submitted: 2/22/2010 8:26:21 PM : Underperform Start Price: $9.42 ELOS Score: +77.77

It's profits are shrinking that's just not a good sign long term.

Recs

0
Member Avatar jerseytix (48.64) Submitted: 5/8/2009 6:04:07 AM : Underperform Start Price: $7.38 ELOS Score: +88.20

Stock is trading just above cash but there is significant macro pressure on elective surgery, plus competition from Cutera, Cynosure and Candela. There's a reason all 4 stocks are trading at enterprise value, because all 4 aren't going to make it through this recession.

Recs

1
Member Avatar lllchicalll (79.02) Submitted: 2/15/2009 5:35:04 PM : Outperform Start Price: $5.86 ELOS Score: -87.64

bravobevo

Recs

0
Member Avatar RockyNicky3728S (< 20) Submitted: 12/25/2008 3:41:52 PM : Outperform Start Price: $7.86 ELOS Score: -110.90

Great growth and future earnings.

Recs

0
Member Avatar ValueMrk (99.61) Submitted: 11/24/2008 9:06:28 AM : Outperform Start Price: $6.49 ELOS Score: -100.43

Medical technology good long-term value.

Recs

0
Member Avatar WhyBeI (57.09) Submitted: 11/14/2008 4:36:56 PM : Outperform Start Price: $7.75 ELOS Score: -113.76

Sells at cash value. Are you kidding?

Recs

2
Member Avatar tenmiles (99.34) Submitted: 10/20/2008 1:16:09 PM : Outperform Start Price: $9.87 ELOS Score: -116.61

Deep value play for a number of prominent investors has become an even deeper value after recent earnings miss. Sub $10 looks like good entry point - technicals suggest we are nearing short-term bottom, while value metrics seem compelling - debt free, 60% of market cap in cash, small premium to book. Likely dead money for a while, but solid 3-5 year recovery prospects from current level.

Recs

0
Member Avatar EagleTraderOne (< 20) Submitted: 9/10/2008 4:54:35 PM : Underperform Start Price: $14.60 ELOS Score: +104.67

Still a way to go...down. Not a buy...yet.

Recs

0
Member Avatar kaz324 (< 20) Submitted: 8/30/2008 4:11:41 PM : Outperform Start Price: $16.65 ELOS Score: -102.57

Technical bottom, Fantastic balance sheet, net income to sales ratio is high (20 to 50%), no capital needed to grow, tiny depreciation charge, some great and famous individual investors are accumulating it. What I call a growth company at a value price.

Recs

2
Member Avatar chaga269 (85.03) Submitted: 8/7/2008 4:39:24 PM : Underperform Start Price: $14.32 ELOS Score: +97.13

People might not be too excited about spending more money on their products, while the credit card debt, mortgage, prices in general are all increasing. Also, more people are losing their jobs. Might be best to stay away from these stocks for now.

Recs

0
Member Avatar outoffocus (23.24) Submitted: 7/13/2008 10:58:44 PM : Outperform Start Price: $14.93 ELOS Score: -101.66

This company has solid fundamentals. Low Price to book ratio. Low debt to equity and solid earnings. In this bear market you need whatever good companies you can find.

Recs

1
Member Avatar gilliam1983 (< 20) Submitted: 7/3/2008 2:59:20 AM : Outperform Start Price: $14.93 ELOS Score: -99.35

You gotta love a BEAR market. There are so many great stocks trading at levels I usually only dream about. Not much of a downside here. Expect a minimum of a 50% return, but closer to 75-100%. Dont b fooled fools, this is know value trap. 0 debt and mgmt buying back shares.

Recs

1
Member Avatar jonlanglois (67.72) Submitted: 6/17/2008 11:46:01 AM : Outperform Start Price: $17.56 ELOS Score: -99.37

I've held this stock since before the October plunge...I do think it was overdone. The company still seems well-managed. The larger trend of an aging population bodes well for its product line, though the near-term economic uncertainty might make customers a bit hesitant.

Recs

1
Member Avatar stohks (< 20) Submitted: 5/26/2008 6:35:28 PM : Outperform Start Price: $16.37 ELOS Score: -93.13

because I am putting my money where my mouth is.

Recs

1
Member Avatar SportAg22 (< 20) Submitted: 4/29/2008 12:45:35 AM : Outperform Start Price: $15.10 ELOS Score: -86.14

Important to note that insurances are covering/reimbursing certain procedures!

Recs

0
Member Avatar TripleTTT (< 20) Submitted: 3/26/2008 4:59:37 PM : Outperform Start Price: $14.83 ELOS Score: -90.79

Safety & hi growth potential

Recs

0
Member Avatar JackMcKay (27.74) Submitted: 3/7/2008 11:16:29 PM : Outperform Start Price: $16.65 ELOS Score: -101.56

Full Syneron Analysis:
http://solidstocks.blogspot.com/2008/02/long-case-for-syneron.html

Excerpt: "Investors rewarded Syneron's sterling growth in its infancy with an inflated share price and amplified expectations. Since, competitive pressures that have slowed sales and earnings growth and an increasingly difficult macroeconomic environment that has raised concern over consumer demand for expensive procedures have dampened investor sentiment regarding Syneron. Just as investors overcompensated for Syneron's successes on the ride up (shares traded for over $40 in 2005 after trading for $11 the previous year), investors have overcompensated in response to Syneron's recent performance, bidding down shares to $14 after trading for $27 less than a year ago. Meanwhile, the company's continued solid performance "where it counts" received scant attention. Syneron has gained market share and grown cash flow while competitors fizzled. Indeed, Syneron's recent 4Q 2007 report, showed a 21M cash from operations figure, lifting shares up to today's price ($16.19)."

Results 1 - 20 of 95 : 1 2 3 4 5 Next »

Featured Broker Partners


Advertisement